Author Details

Name: Càndid Villanueva

Affiliations: Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain.

Publications

• Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: a post-hoc analysis of the PREDESCI trial.

• Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

• Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data.

• Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding.

• Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.

• Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.

• Non-invasive tests for clinically significant portal hypertension after HCV cure.

• Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.

• Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.

• Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

• Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.